» Articles » PMID: 10353501

Topical Capsaicin in Humans: Parallel Loss of Epidermal Nerve Fibers and Pain Sensation

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 1999 Jun 3
PMID 10353501
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Capsaicin applied topically to human skin produces itching, pricking and burning sensations due to excitation of nociceptors. With repeated application, these positive sensory responses are followed by a prolonged period of hypalgesia that is usually referred to as desensitization, or nociceptor inactivation. Consequently, capsaicin has been recommended as a treatment for a variety of painful syndromes. The precise mechanisms that account for nociceptor desensitization and hypalgesia are unclear. The present study was performed to determine if morphological changes of intracutaneous nerve fibers contribute to desensitization and hypalgesia. Capsaicin (0.075%) was applied topically to the volar forearm four times daily for 3 weeks. At various time intervals tactile, cold, mechanical and heat pain sensations were assessed in the treated and in contralateral untreated areas. Skin blisters and skin biopsies were collected and immunostained for protein gene product (PGP) 9.5 to assess the morphology of cutaneous nerves and to quantify the number of epidermal nerve fibers (ENFs). Capsaicin resulted in reduced sensitivity to all cutaneous stimuli, particularly to noxious heat and mechanical stimuli. This hypalgesia was accompanied by degeneration of epidermal nerve fibers as evidenced by loss of PGP 9.5 immunoreactivity. As early as 3 days following capsaicin application, there was a 74% decrease in the number of nerve fibers in blister specimens. After 3 weeks of capsaicin treatment, the reduction was 79% in blisters and 82% in biopsies. Discontinuation of capsaicin was followed by reinnervation of the epidermis over a 6-week period with a return of all sensations, except cold, to normal levels. We conclude that degeneration of epidermal nerve fibers contributes to the analgesia accredited to capsaicin. Furthermore, our data demonstrate that ENFs contribute to the painful sensations evoked by noxious thermal and mechanical stimuli.

Citing Articles

Slow depolarizing electrical stimuli reveal differential time courses of nociceptor recovery after prolonged topical capsaicin in human skin.

Tumbala Gutti D, Carr R, Schmelz M, Rukwied R Eur J Pain. 2024; 29(2):e4726.

PMID: 39297430 PMC: 11671321. DOI: 10.1002/ejp.4726.


Capsaicin: Emerging Pharmacological and Therapeutic Insights.

Petran E, Periferakis A, Troumpata L, Periferakis A, Scheau A, Badarau I Curr Issues Mol Biol. 2024; 46(8):7895-7943.

PMID: 39194685 PMC: 11352336. DOI: 10.3390/cimb46080468.


Identification of compounds that cause axonal dieback without cytotoxicity in dorsal root ganglia explants and intervertebral disc cells with potential to treat pain via denervation.

Lee F, Nguyen U, Munns E, Wachs R PLoS One. 2024; 19(5):e0300254.

PMID: 38696450 PMC: 11065314. DOI: 10.1371/journal.pone.0300254.


Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.

Mallick-Searle T, Adler J J Pain Res. 2024; 17:1005-1028.

PMID: 38505500 PMC: 10949339. DOI: 10.2147/JPR.S442595.


Inducible desensitization to capsaicin with repeated low-dose exposure in human volunteers.

Nolden A, Lenart G, Spielman A, Hayes J Physiol Behav. 2023; 275:114447.

PMID: 38135109 PMC: 10842799. DOI: 10.1016/j.physbeh.2023.114447.